EGFR and squamous cell carcinoma: Based on these observations, we hypothesized that C225 can enhance cytotoxicity with the PARPi ABT-888 in UM-SCC1, UM-SCC6, and FaDu cells, which are well characterized, EGFR overexpressing, representative squamous cell carcinoma of the head and neck [17]–[20].